EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Successful treatment of acyclovir‐resistant herpes simplex virus infection with amenamevir in a patient who received umbilical cord blood transplantation for T‐cell prolymphocytic leukemia

Yuma Kawamura iD, Nako Uchibori, Tomoya Arakawa, Tomoki Fujii, Shuto Negishi, Shiori Morikawa, Nobuaki Fukushima, Akio Kohno, Souichi Yamada, Yoshiko Fukui, Shuetsu Fukushi, Kazutaka Ozeki

eJHaem · 2024-06 · 5 (3) · 616-619

DOI: 10.1002/jha2.899 ↗

Kurz gefasst

Fallbericht in der Zeitschrift eJHaem, online erschienen am 29.04.2024. Verfasst von Yuma Kawamura und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Oncology Konan Kosei Hospital Konan Japan. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A 34‐year‐old woman received umbilical cord blood transplantation for refractory T‐cell prolymphocytic leukemia after salvage therapy with alemtuzumab. She developed right angular cheilitis on the 46th day after transplantation, which worsened after receiving systemic steroid therapy for extensive chronic graft versus host disease. The treatment dosage of acyclovir (ACV), ganciclovir, and vidarabine ointment was not effective due to ACV‐resistant mutations of the herpes simplex virus type 1 (HSV‐1) in the thymidine kinase domain. Foscarnet is expected to be effective against ACV‐resistant HSV‐1 infection. However, it could not be used because the patient developed renal dysfunction. Several viral thymidine kinase mutations related to ACV resistance were found in the patient's sample. Nevertheless, amenamevir, a helicase‐primase complex inhibitor, was effective in our patient who was significantly immunocompromised after allogeneic hematopoietic stem cell transplantation (allo‐HSCT). ACV‐resistant HSV infection after allo‐HSCT is an rare but important complication in the era of low‐dose long‐term ACV prophylaxis. To date, there is no established treatment against ACV‐resistant HSV infection. This case report showed that amenamevir could be a promising treatment option for ACV‐resistant HSV infection in patients with renal failure after allo‐HSCT.

Schlagwörter

Stichwörter der Autor:innen

T‐Cellacycloviralemutuzumabamenamevircord blood stem cell transplantationfoscarnetherpes simplexhomologousleukemiaprolymphocyticsimplex virustransplantation

Autor:innen und Institutionen

  • Department of Hematology and Oncology Konan Kosei Hospital Konan Japan.
  • Department of Dermatology Konan Kosei Hospital Konan Japan.
  • Department of Virology 1 National Institute of Infectious Diseases Tokyo Japan.

ORCID-Profile: Yuma Kawamura

Zitieren

APA

Kawamura, Y., Uchibori, N., Arakawa, T., Fujii, T., Negishi, S., Morikawa, S., Fukushima, N., Kohno, A., Yamada, S., Fukui, Y., Fukushi, S., & Ozeki, K. (2024). Successful treatment of acyclovir‐resistant herpes simplex virus infection with amenamevir in a patient who received umbilical cord blood transplantation for T‐cell prolymphocytic leukemia. eJHaem, 5(3), 616-619. https://doi.org/10.1002/jha2.899

Vancouver

Kawamura Y, Uchibori N, Arakawa T, Fujii T, Negishi S, Morikawa S, et al. Successful treatment of acyclovir‐resistant herpes simplex virus infection with amenamevir in a patient who received umbilical cord blood transplantation for T‐cell prolymphocytic leukemia. eJHaem. 2024;5(3):616-619. doi:10.1002/jha2.899

BibTeX
@article{Kawamura2024,
  author = {Kawamura, Yuma and Uchibori, Nako and Arakawa, Tomoya and Fujii, Tomoki and Negishi, Shuto and Morikawa, Shiori and Fukushima, Nobuaki and Kohno, Akio and Yamada, Souichi and Fukui, Yoshiko and Fukushi, Shuetsu and Ozeki, Kazutaka},
  title = {Successful treatment of acyclovir‐resistant herpes simplex virus infection with amenamevir in a patient who received umbilical cord blood transplantation for T‐cell prolymphocytic leukemia},
  journal = {eJHaem},
  year = {2024},
  volume = {5},
  number = {3},
  pages = {616--619},
  doi = {10.1002/jha2.899}
}
Kostenlos starten →